SuperworthenVVeno Medical price to sales ratio NVNO
Market value divided by revenue over the last twelve months, since 2019.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 194×
- Apr 2020
- Peer median
- 1.4×
enVVeno Medical's price to sales ratio is not a meaningful number today: revenue for one or more of the four quarters through 2026-06-30 is missing, so twelve months can't be added up.
It was last meaningful in Apr 2020, at 194×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2020 | 194× | 107× | 199× |
| 2019 | 142× | 74.6× | 187× |
Against its peers
Companies in Healthcare nearest enVVeno Medical's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| NVNOenVVeno Medical | n/m |
| OXBROXBRIDGE RE HOLDINGS | 2.8× |
| EDUCEducational Development | 0.4× |
| GTIMGood Times Restaurants | 0.1× |
| MDRRMedalist Diversified | 1.6× |
| BCGBinah Capital | 0.1× |
| VIPVulcan Infrastructure & Power | 0.4× |
| MXCMexco Energy | 3.0× |
| CKXCKX Lands | 31.0× |
| MSGMMotorsport Games | 1.5× |
| ATCHAtlasClear | 1.2× |
| Peer median | 1.4× |
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on enVVeno Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.